William Rastetter

William H.
Rastetter founded Apoptos, Inc. in 2007, where he worked as Chairman & Chief Executive Officer in 2009, Receptos LLC in 2009, where he worked as Executive Chairman from 2010 to 2015, and GRAIL, Inc. in 2015, where he worked as Director from 2018 to 2021.
Dr. Rastetter also founded San Diego Squared, where he is working as Chairman.
Dr. Rastetter also currently works at Neurocrine Biosciences, Inc., as Chairman from 2011, Fate Therapeutics, Inc., as Chairman from 2012, Daré Bioscience, Inc., as Independent Chairman from 2019, CONNECT, as Director, Iambic Therapeutics, Inc., as Director, iambic, Inc. (California), as Director, Leerink Partners LLC, as Advisor, California Institute of Technology, as Trustee, and IIF Management Co. LLC, as Advisor.
Dr. Rastetter also formerly worked at Celgene Corp., as Chairman & Chief Executive Officer from 2009 to 2015, IDEC Pharmaceuticals Corp., as Chairman & Chief Executive Officer from 1996 to 2003, Biogen, Inc., as Executive Chairman from 2003 to 2005, Illumina, Inc., as Chairman from 2005 to 2016, Regulus Therapeutics, Inc., as Chairman in 2013, Cerulean Pharma, Inc., as Chairman from 2016 to 2017, Biogen Idec, Inc. (North Carolina), as Executive Chairman from 2003 to 2005, Genentech, Inc., as Director-Corporate Ventures from 1982 to 1986, Venrock Associates, as Partner from 2006 to 2013, Harvard University, as Faculty Member, Massachusetts Institute of Technology, as Associate Professor from 1975 to 1982, and MPRD Ltd., as Board of Trustees.
Dr. Rastetter received his graduate degree and doctorate degree from Harvard University and undergraduate degree from Massachusetts Institute of Technology.